On April 15 , Xu Hong, the second-level inspector of the Provincial Bureau, led the relevant comrades from the licensing and registration office to Hefei Huafang Pharmaceutical Technology Co., Ltd. to conduct field research on the company's drug research and development innovation work.

Xu Hong and his party visited the company's R&D center and laboratory site, listened to the introduction of the person in charge of the company on the R&D innovation and transformation of scientific and technological achievements of Huafang Medicine in recent years, and had a discussion with the company's R&D, registration departments and postdoctoral staff. , on-site answers to the problems faced by enterprises in terms of variety transfer and production line construction after obtaining the production license of drug marketing holders. Xu Hong pointed out that Huafang Pharmaceutical has earnestly practiced the development strategy of "scientific and technological innovation" for 18 years, actively devoted itself to the research and development, transformation and industrialization of the pharmaceutical field, and has strong innovation capabilities. Especially recently, the company has successfully broken through the core technology of osmotic pump controlled-release preparations "stuck neck", and the independently developed "Key Technology Breakthrough in R&D of Oral Solid Preparations and Industrial Application" project won the first prize of Anhui Science and Technology Progress Award in 2020, with innovative achievements Remarkable.

Xu Hong emphasized that the pharmaceutical industry is a sunrise industry with broad development prospects. The provincial and municipal governments have provided a very favorable environment for the development of the pharmaceutical industry in recent years. As one of the professional drug research and development institutions that started early in our province and has the most DDS scientific research platforms, Huafang Medicine should seize the opportunity, take advantage of the momentum, rely on academician workstations and other experts and technical teams, further increase the strength of drug research and development innovation, and strive to A number of new and good drugs with international competitiveness have been developed. The Anhui Provincial Bureau will combine the functions of drug supervision, strive to create a first-class business environment in the region, and play a greater role in serving the province's "double recruitment and double introduction" work.

Xu Hong said that in the next step, the Provincial Bureau will continue to strengthen the service guarantee for innovative pharmaceutical enterprises, combine the party history education and learning activities, actively help enterprises to solve difficulties, and provide enterprises with policy, information, technology and other consulting services and technical guidance , accelerate the integration of pharmaceutical companies in our province into the Yangtze River Delta, and help the high-quality development of pharmaceutical companies in our province.